Indian pharmaceutical industry wants to lead the global pharmaceutical market
Release time: 2010-11-12 & nbsp & nbsp & nbsp Source:
Indian Pharmaceutical Industry has always relying on the cheap drugs that it produces to defeat the products of Western countries to sell to developing countries,Although it is criticized by the West,But it benefits greatly,It is expected to increase 13%this year,The benefits of the entire industry will exceed $ 24 billion。According to the Indian government statistics,2008 ~ 2009 During the fiscal year,Indian drug and pharmaceutical industry service export value reached 8.3 billion U.S. dollars,25%increase over a year ago。
Due to the sharp decrease in the work of the pharmaceutical industry in the Western country,Make the Indian pharmaceutical industry more prosperous development opportunities,Take Sun Pharmaceutical Company based on Rahar as an example,The company made a profit of $ 880 million in 2009,This year's expected sales volume will increase at a rate of 20%。With India's strengthening management of the patent law,Plus My stake betting appthe stake sports betting appmajor Western drug manufacturers tired of cost pressure,Indian pharmaceutical industry, which is mainly based on basic drugs, will play a more mainstream role in the global pharmaceutical market。President Plamar, Pharmaceutical Manufacturer, Pharmaceutical Manufacturer of Mumbai, said,India is becoming a manufacturing base for the global pharmaceutical market,Point out,In the future, the Western Pharmaceutical Giants will only operate the original and final steps of the drug -molecular drug discovery and market operation。Ordinary cure and epilepsy drugs produced by SUN company for the purpose of exporting to the United States,Current,The United States has become India's largest drug exporter。
Not only the executives of major pharmaceutical companies in India are optimistic about the prospects of Indian Pharmaceuticals,Analysts、Research institutions and consulting companies have also made similar optimistic predictions in recent months。
In order to be a hero in the global pharmaceutical market,India's major pharmaceutical companies have taken some measures for this purpose。
First, through mergers and acquisitions and cooperation,Play the foundation for expanding production。Recent,Plamar Health Company sold its ordinary drug manufacturing business to Abbott Pharmaceutical Company,It is the most merger and acquisition and joint venture; Japan's No. 1 and Three Pharmaceuticals helped India out of the door of foreign drugs by purchasing the shares of the largest pharmaceutical company in India in 2008; Ke and Dr. Rydi's Pharmaceutical Company formed a cooperative company; Last year, Pfizer and Carey Life Science Pharmaceutical Company formed an alliance; Sanofian Wande acquired SHANTHA Biotechnology Company,and Beltay Shi Guibao cooperated with Baikang Company to open a research center in India。
My stake betting appSecond, the introduction and stake betting appoutsourcing together。Because India has a large number of outstanding talents with low labor costs,Very coveted by Western pharmaceutical companies,At present, some Western drug manufacturing、Including packaging and even component sectors, it is also transferred to India。
At the same time,Indian Pharmaceutical Industry, which has always been proud of the outsourcing business recently, is considering improving the value chain of the industry。India is particularly high -quality、There are obvious advantages in low -cost drugs,According to industry insiders forecast,All aspects on the value chain of the pharmaceutical industry in the next few years will transfer to the world at a low price.,India will get huge benefits based on this。
Third is to develop more cut -end medicines,Including developing and developing special medicines for the World Pharmaceutical Giants。The main laboratory of Plamar Health Company, located in northern Mumbai, has more than 300 scientists,Now is working hard to develop and treat inflammation、New medicine for metabolic disorders and cancer。Due to low labor cost,So the company's chairman forecast,If the cost of developing new drugs in Western companies is between 10-5 billion US dollars,We only spend 1/10 of them are enough。and the chief head of Dr. Rydi's Pharmaceutical Company Plaosade, it is called,Indian pharmaceutical dealers have the ability to develop new drugs at a low -cost large scale,The company's original diabetic drugs were approved by the US Food and Drug Administration (FDA) after completing the third stage of clinical trials,The fastest obtained from similar companies。
Although the Indian pharmaceutical industry has many potential,But there are many problems that need to be solved in the goal of being called Stake Sports Bettingthe male world market:
First is the problem of drug quality control。stake betting appFDA pointed out,In recent years, Lambax has repeatedly violated the production specifications and ordered the company to review the global pharmaceutical industry in February this year。In May Sanofiand Elt recalls the vaccine produced by ShanTha Biotechnology Company,User is reflected in the bottle with white sediment。In June, some IV -type plastic bags were found to contain floating objects,Pfizer Carey recalls injections produced by biological science companies and sold in the United States。
Followed by intellectual property issues。India has always been known for not following the production of patent laws,To change its adverse image,Implementing strengthen supervision of the Patent Law in 2005。Despite this,Litigation cases of Indian companies and foreign companies have repeatedly occurred around the world。At the same time,India's imitation foreign drug phenomenon is still very rampant,According to a research report on a drug entered from Indian wholesalers this year,About 3.6%of the medicines contain any ingredients without any efficacy。Therefore,Some senior executives in the US pharmaceutical industry think,Their Indian counterparts are too optimistic about their prospects。
But,With the influence of the Indian pharmaceutical industry in the world,FDA opened two offices in Delhi and Mumbai,Each will be equipped with 12 full -time staff,Including technical experts and inspectors,to ensure that drugs imported to the United States meet the needs of the United States for health and safety。Current,FDA has allowed 900 Indian pharmaceutical companies to export drugs and related raw materials to the United States,and only 300 Chinese companies that allow exports to the United States。According stake betting appto Frost&SULLIVAN company research analyst said,Because India stake online sports bettinghas a lot of things to provide,and there are huge cost advantages,So he predicts that in the near future, the international pharmaceutical giant will buy more products of Indian companies。and Chinese pharmaceutical companies are unable to produce cutting -edge drugs,"If you want to produce aspirin, such as aspirin,Then go to China。”
Due to the sharp decrease in the work of the pharmaceutical industry in the Western country,Make the Indian pharmaceutical industry more prosperous development opportunities,Take Sun Pharmaceutical Company based on Rahar as an example,The company made a profit of $ 880 million in 2009,This year's expected sales volume will increase at a rate of 20%。With India's strengthening management of the patent law,Plus My stake betting appthe stake sports betting appmajor Western drug manufacturers tired of cost pressure,Indian pharmaceutical industry, which is mainly based on basic drugs, will play a more mainstream role in the global pharmaceutical market。President Plamar, Pharmaceutical Manufacturer, Pharmaceutical Manufacturer of Mumbai, said,India is becoming a manufacturing base for the global pharmaceutical market,Point out,In the future, the Western Pharmaceutical Giants will only operate the original and final steps of the drug -molecular drug discovery and market operation。Ordinary cure and epilepsy drugs produced by SUN company for the purpose of exporting to the United States,Current,The United States has become India's largest drug exporter。
Not only the executives of major pharmaceutical companies in India are optimistic about the prospects of Indian Pharmaceuticals,Analysts、Research institutions and consulting companies have also made similar optimistic predictions in recent months。
In order to be a hero in the global pharmaceutical market,India's major pharmaceutical companies have taken some measures for this purpose。
First, through mergers and acquisitions and cooperation,Play the foundation for expanding production。Recent,Plamar Health Company sold its ordinary drug manufacturing business to Abbott Pharmaceutical Company,It is the most merger and acquisition and joint venture; Japan's No. 1 and Three Pharmaceuticals helped India out of the door of foreign drugs by purchasing the shares of the largest pharmaceutical company in India in 2008; Ke and Dr. Rydi's Pharmaceutical Company formed a cooperative company; Last year, Pfizer and Carey Life Science Pharmaceutical Company formed an alliance; Sanofian Wande acquired SHANTHA Biotechnology Company,and Beltay Shi Guibao cooperated with Baikang Company to open a research center in India。
My stake betting appSecond, the introduction and stake betting appoutsourcing together。Because India has a large number of outstanding talents with low labor costs,Very coveted by Western pharmaceutical companies,At present, some Western drug manufacturing、Including packaging and even component sectors, it is also transferred to India。
At the same time,Indian Pharmaceutical Industry, which has always been proud of the outsourcing business recently, is considering improving the value chain of the industry。India is particularly high -quality、There are obvious advantages in low -cost drugs,According to industry insiders forecast,All aspects on the value chain of the pharmaceutical industry in the next few years will transfer to the world at a low price.,India will get huge benefits based on this。
Third is to develop more cut -end medicines,Including developing and developing special medicines for the World Pharmaceutical Giants。The main laboratory of Plamar Health Company, located in northern Mumbai, has more than 300 scientists,Now is working hard to develop and treat inflammation、New medicine for metabolic disorders and cancer。Due to low labor cost,So the company's chairman forecast,If the cost of developing new drugs in Western companies is between 10-5 billion US dollars,We only spend 1/10 of them are enough。and the chief head of Dr. Rydi's Pharmaceutical Company Plaosade, it is called,Indian pharmaceutical dealers have the ability to develop new drugs at a low -cost large scale,The company's original diabetic drugs were approved by the US Food and Drug Administration (FDA) after completing the third stage of clinical trials,The fastest obtained from similar companies。
Although the Indian pharmaceutical industry has many potential,But there are many problems that need to be solved in the goal of being called Stake Sports Bettingthe male world market:
First is the problem of drug quality control。stake betting appFDA pointed out,In recent years, Lambax has repeatedly violated the production specifications and ordered the company to review the global pharmaceutical industry in February this year。In May Sanofiand Elt recalls the vaccine produced by ShanTha Biotechnology Company,User is reflected in the bottle with white sediment。In June, some IV -type plastic bags were found to contain floating objects,Pfizer Carey recalls injections produced by biological science companies and sold in the United States。
Followed by intellectual property issues。India has always been known for not following the production of patent laws,To change its adverse image,Implementing strengthen supervision of the Patent Law in 2005。Despite this,Litigation cases of Indian companies and foreign companies have repeatedly occurred around the world。At the same time,India's imitation foreign drug phenomenon is still very rampant,According to a research report on a drug entered from Indian wholesalers this year,About 3.6%of the medicines contain any ingredients without any efficacy。Therefore,Some senior executives in the US pharmaceutical industry think,Their Indian counterparts are too optimistic about their prospects。
But,With the influence of the Indian pharmaceutical industry in the world,FDA opened two offices in Delhi and Mumbai,Each will be equipped with 12 full -time staff,Including technical experts and inspectors,to ensure that drugs imported to the United States meet the needs of the United States for health and safety。Current,FDA has allowed 900 Indian pharmaceutical companies to export drugs and related raw materials to the United States,and only 300 Chinese companies that allow exports to the United States。According stake betting appto Frost&SULLIVAN company research analyst said,Because India stake online sports bettinghas a lot of things to provide,and there are huge cost advantages,So he predicts that in the near future, the international pharmaceutical giant will buy more products of Indian companies。and Chinese pharmaceutical companies are unable to produce cutting -edge drugs,"If you want to produce aspirin, such as aspirin,Then go to China。”
